Ticker Scorecard - ADMA Basics Company: ADMA Biologics Inc IPO Date: October 18, 2013 Sector: Healthcare Industry: Biotech Market Cap: $4.12B Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 2.80% Avg Daily Range (30 D): $0.48 | 2.54% Avg Daily Range (90 D): $0.47 | 2.46% Institutional Daily Volume Avg Daily Volume: 1.52M Avg Daily Volume (30 D): 1.8M Avg Daily Volume (90 D): 3.19M Trade Size Avg Trade Size (Sh.): 222 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 1,329 Avg Inst. Trade: $3.16M Avg Inst. Trade (30 D): $4.05M Avg Inst. Trade (90 D): $5.87M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.36M Avg Closing Trade (30 D): $8.69M Avg Closing Trade (90 D): $15.25M Avg Closing Volume: 513.89K     News Nov 2, 2024 @ 10:18 AM BFA Law is Investigating ADMA BIOLOGICS for Securi... Source: N/A Oct 27, 2024 @ 12:06 PM ADMA FRAUD ALERT: BFA Law Notifies ADMA Biologics ... Source: N/A Oct 19, 2024 @ 10:28 AM ADMA INVESTIGATION UPDATE: ADMA Biologics Investor... Source: N/A Oct 17, 2024 @ 3:00 PM ADMA Biologics ALERT: Securities Fraud Investigati... Source: Block & Leviton Oct 15, 2024 @ 8:00 PM ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossm... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q2 2024 Q1 2024 Basic EPS $.15 $.14 $.08 Diluted EPS $.15 $.13 $.08 Revenue $ 119.84M $ 107.19M $ 81.88M Gross Profit $ 59.66M $ 57.45M $ 39.11M Net Income / Loss $ 35.91M $ 32.06M $ 17.81M Operating Income / Loss $ 39.64M $ 39.2M $ 21.82M Cost of Revenue $ 60.18M $ 49.74M $ 42.77M Net Cash Flow $ -1.54M $ 42.92M $ -6.03M PE Ratio 111.40